Chemical Compound
Cephalotaxine, 3-[4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate]; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI); Homoharringtonine (8CI); CGX 635; Ceflatonin; Myelostat; NSC 141633; Omacetaxine mepesuccinate; Synribo
CAS Registry Number
26833-87-4
Primary record
Cephalotaxine, 3-[4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate]; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI); Homoharringtonine (8CI); CGX 635; Ceflatonin; Myelostat; NSC 141633; Omacetaxine mepesuccinate; Synribo
- 库存
- 4,861 克
- 纯度
- 99.0 %
- CAS
- 26833-87-4
化合物标识与属性
- CAS
- 26833-87-4
- PubChem CID
- 285033
- SMILES
- CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
- Canonical SMILES
- COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4
名称与同义词
- homoharringtonine
- Omacetaxine mepesuccinate
- Ceflatonin
- Myelostat
- Synribo
- Omapro
- Homoharringtonin
- Omacetaxine
- 26833-87-4
- Tekinex
- (-)-homoharringtonine
- CGX-635
- Synribo (TN)
- omacetaxini mepesuccinas
- mepesuccinate d'omacetaxine
- mepesuccinato de omacetaxina
- NSC-141633
- RefChem:56718
- AC1Q5YWQ
- ZJ-C
- CHEBI:71019
- D0M4XY
- C29H39NO9
- UNII-6FG8041S5B
- Cephalotaxine, [3(R)]-
- Omacetaxine (homoharringtonine)
- 6FG8041S5B
- Homoharringtonine (Standard)
- Homoharringtonine, food grade
- Omacetaxine mepesuccinate;HHT
- MLS001424293
- CHEMBL46286
- HOMOHARRINGTONINE [MI]
- NSC 141633
- Omacetaxine mepesuccinate [USAN]
- HYFHYPWGAURHIV-JFIAXGOJSA-N
- MFCD05618221
- CGX-635-14 (formulation)
- GTPL7454
- DTXCID8025678
- DTXSID0045678
- SCHEMBL12745687
- SCHEMBL30517017
- CTK8E8620
- (2'R,3S,4S,5R)-(-)-homoharringtonine
- CGX 635
- L01XX40
- Omacetaxine mepesuccinate (USAN)
- GLXC-04527
- HMS3267H22
- HMS3414N05
- HMS3678N03
- Omacetaxine mepesuccinate [USAN:INN]
- AC1L6273
- AMY33459
- MSK40305
- BRN 5687925
- Homoharringtonine, >=98% (HPLC)
- AR-1K8685
- BDBM50480293
- C29-H39-N-O9
- CID285033
- EBC-17148
- HB4660
- HY-14944R
- NP0539
- NSC141633
- NSC758253
- s9015
- ZINC26011099
- Homoharringtonine - Bio-X trade mark
- AKOS024456585
- ACN-035229
- CCG-269981
- CS-2872
- DB04865
- FH15974
- NC00395
- NSC-758253
- OMACETAXINE MEPESUCCINATE [INN]
- NCGC00025155-01
- NCGC00025155-02
- NCGC00025155-03
- NCGC00025155-04
- NCGC00025155-07
- OMACETAXINE MEPESUCCINATE [MART.]
- OMACETAXINE MEPESUCCINATE [VANDF]
- BH300085
- CPD000469230
- HY-14944
- NCI60_000917
- OMACETAXINE MEPESUCCINATE [WHO-DD]
- SAM001246822
- SMR000469230
- ST056357
- HOMOHARRINGTONINE (REFERENCE GRADE)
- AB0019750
- J123.154E
- TR-031859
- FT-0627081
- FT-0776502
- H1775
- Homoharringtonine|||Omacetaxine mepesuccinate
- N1504
- NS00067000
- V0232
- (2 R,3S,4S,5R)-(-)-Homoharringtonine
- D08956
- homoharringtonine, 3H-labeled, (3(R))-isomer
- OMACETAXINE MEPESUCCINATE [ORANGE BOOK]
- AB00642561-02
- A856348
- C001652
- EN300-22161068
- SR-01000597562
- 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- HHT
- Q7089373
- SR-01000597562-1
- BRD-K76674262-001-01-7
- BRD-K76674262-001-02-5
- BRD-K76674262-001-03-3
- Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester)
- Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)
- 2-Methyl-4-oxo-4-(3',4'-difluorophenyl)butyric acid
- Cephalotaxine 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- cephalotaxine 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- 64131-12-0
- o3-[(2r)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine
- Cephalotaxine (R)-2-(methoxycarbonylmethyl)-2,6-dihydroxy-6-methylheptanoate
- Cephalotaxine, 3-[4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate]
- Cephalotaxine, 4-methyl-, 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)
- (13S,14S,17R)-14-[[(2R)-2,6-Dihydroxy-2-(methoxycarbonylmethyl)-6-methylheptanoyl]oxy]-15-methoxy-7,9-dioxa-1-azapentacyclo[15.3.0.04,12.06,10.013,17]icosane-4,6(10),11,15-tetraene
- (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0^{2,6}.0^{6,10}.0^{15,19}]icosa-1(13),4,14,19-tetraen-3-yl 1-methyl (3R)-3-hydroxy-3-(4-hydroxy-4-methylpentyl)butanedioate
- (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3R)-3-hydroxy-3-(4-hydroxy-4-methylpentyl)butanedioate
- (2S,3S,6S)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0<2,6>.0<6,10>.0<15,1 9>]icosa-1(20),4,13,15(19)-tetraen-3-yl methyl (2R)-2-hydroxy-2-(4-hydroxy-4-m ethylpentyl)butane-1,4-dioate
- (3beta)-O~3~-[(2r)-2,6-Dihydroxy-2-(2-Methoxy-2-Oxoethyl)-6-Methylheptanoyl]cephalotaxine
- (S)-1-((11bS,12S,14aR)-13-methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate
- 1-((11bS,12S,14aR)-13-Methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl (R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate
- 1-((1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H- cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2R)-2- hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- 1-((1S,3AR,14BS)-2-METHOXY-1,5,6,8,9,14B-HEXAHYDRO-4H-CYCLOPENTA(A)(1,3)DIOXOLO(4,5-H)PYRROLO(2,1-B)(3)BENZAZEPIN-1-YL) 4-METHYL (2R)-2-HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE
- 1-[(1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[a][1,3]dioxolo[4,5-H]pyrrolo[2,1-b][3]benzazepin-1-yl] 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- 1-O-((2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo(11.7.0.02,6.06,10.015,19)icosa-1(20),4,13,15(19)-tetraen-3-yl) 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
- Cephalotaxine, 3-[4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate]; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI); Homoharringtonine (8CI); CGX 635; Ceflatonin; Myelostat; NSC 141633; Omacetaxine mepesuccinate; Synribo
- Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), (3(R))-
- Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), [3(R)]-
- O1-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] O4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methyl-pentyl)butanedioate